Decheng Capital as of Dec. 31, 2024
Portfolio Holdings for Decheng Capital
Decheng Capital holds 28 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 39.2 | $183M | 6.4M | 28.68 | |
| Nuvation Bio (NUVB) | 14.8 | $69M | 26M | 2.66 | |
| Upstream Bio (UPB) | 11.6 | $54M | 3.3M | 16.44 | |
| Newamsterdam Pharma Co Nv (NAMS) | 4.2 | $20M | 770k | 25.70 | |
| Illumina (ILMN) | 2.7 | $13M | 95k | 133.63 | |
| Arcus Biosciences Incorporated (RCUS) | 2.6 | $12M | 809k | 14.89 | |
| Krystal Biotech (KRYS) | 2.6 | $12M | 77k | 156.66 | |
| Revolution Medicines (RVMD) | 2.1 | $9.9M | 226k | 43.74 | |
| Helix Acquisition Corp | 2.0 | $9.3M | 172k | 54.15 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.8 | $8.6M | 168k | 51.13 | |
| BeyondSpring SHS (BYSI) | 1.7 | $8.0M | 4.9M | 1.63 | |
| Merus N V (MRUS) | 1.7 | $8.0M | 189k | 42.05 | |
| Lyell Immunopharma | 1.6 | $7.6M | 12M | 0.64 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $7.1M | 2.3M | 3.03 | |
| Arcellx (ACLX) | 1.4 | $6.5M | 84k | 76.69 | |
| Phathom Pharmaceuticals (PHAT) | 1.2 | $5.6M | 694k | 8.12 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $5.6M | 2.3M | 2.48 | |
| Legend Biotech Corp- Adr (LEGN) | 1.1 | $5.0M | 154k | 32.54 | |
| Cytokinetics (CYTK) | 1.0 | $4.7M | 100k | 47.04 | |
| Biontech Se (BNTX) | 1.0 | $4.6M | 40k | 113.95 | |
| Aura Biosciences (AURA) | 0.9 | $4.2M | 516k | 8.22 | |
| Equillium (EQ) | 0.7 | $3.3M | 4.4M | 0.75 | |
| 4d Molecular Therapeutics In (FDMT) | 0.5 | $2.2M | 400k | 5.57 | |
| Vera Therapeutics (VERA) | 0.5 | $2.1M | 50k | 42.29 | |
| AtriCure (ATRC) | 0.2 | $819k | 27k | 30.56 | |
| Pyxis Oncology (PYXS) | 0.1 | $510k | 327k | 1.56 | |
| Grail (GRAL) | 0.0 | $173k | 9.7k | 17.85 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $149k | 646k | 0.23 |
